News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
371,429 Results
Type
Article (24532)
Company Profile (116)
Press Release (346773)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (105234)
Career Advice (426)
Deals (15811)
Drug Delivery (98)
Drug Development (31872)
Employer Resources (61)
FDA (8308)
Job Trends (8203)
News (150520)
Policy (14191)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (11)
2027 BioCapital Standard (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (2154)
Accelerated approval (39)
ADA (30)
Adcomms (17)
Allergies (111)
Alliances (26168)
ALS (127)
Alzheimer's disease (1079)
Antibody-drug conjugate (ADC) (280)
Approvals (8976)
Artificial intelligence (566)
ASCO (145)
Autoimmune disease (204)
Automation (43)
Bankruptcy (129)
Belgium (21)
Best Places to Work (7026)
BIO (40)
Biologics (49)
BIOSECURE Act (14)
Biosimilars (206)
BioSpace Insights (80)
Biotechnology (59)
Bispecific (19)
Bladder cancer (151)
Brain cancer (57)
Breast cancer (534)
Cancer (4031)
Cardiovascular disease (334)
Career advice (414)
Career pathing (14)
CAR-T (187)
CDC (31)
CDMO (116)
Celiac Disease (1)
Cell therapy (511)
Cervical cancer (41)
Clinical research (28707)
Collaboration (1434)
Commercialization (41)
Company closure (3)
Compensation (234)
Complete response letters (39)
COVID-19 (1726)
CRISPR (86)
CRO (5)
C-suite (944)
Cystic fibrosis (79)
Data (5387)
Decentralized trials (3)
Denatured (18)
Depression (98)
Dermatology (123)
Diabetes (406)
Diagnostics (5016)
Digital health (60)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (212)
Drug pricing (117)
Drug shortages (12)
Duchenne muscular dystrophy (137)
Earnings (30980)
Editorial (36)
Employer branding (5)
Employer resources (58)
ESMO (201)
Events (72754)
Executive appointments (795)
Eye disease (16)
FDA (11024)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (13)
Frontotemporal dementia (30)
Funding (1424)
Gene editing (146)
Generative AI (38)
Gene therapy (411)
GLP-1 (525)
Government (2502)
Grass and pollen (4)
Guidances (259)
Healthcare (12972)
Hematology (131)
HIV (75)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (63)
Immunology and inflammation (111)
Immuno-oncology (67)
Indications (163)
Infectious disease (1953)
Inflammatory bowel disease (129)
Inflation Reduction Act (9)
Influenza (82)
Intellectual property (136)
Interviews (47)
IPO (6923)
IRA (31)
Job creations (1357)
Job search strategy (372)
JPM (60)
Kidney cancer (18)
Kidney disease (79)
Labor market (79)
Layoffs (258)
Leadership (10)
Legal (3218)
Licensing (63)
Liver cancer (58)
Longevity (28)
Lung cancer (513)
Lung diease (11)
Lymphoma (304)
Machine learning (35)
Management (21)
Manufacturing (627)
Marketing (27)
MASH (143)
Medical affairs (2)
Medical device (8690)
Medtech (8902)
Melanoma (120)
Mergers & acquisitions (9873)
Metabolic disorders (957)
Middle East (2)
mRNA (140)
Multiple sclerosis (161)
Multispecific (2)
NASH (7)
Netherlands (27)
Neurodegenerative disease (263)
Neuropsychiatric disorders (51)
Neuroscience (2076)
Neurotech (2)
NextGen: Class of 2026 (4201)
Non-profit (3190)
Now hiring (44)
Obesity (382)
Opinion (166)
Ovarian cancer (168)
Pain (164)
Pancreatic cancer (208)
Parkinson's disease (197)
Partnered (21)
Patents (265)
Patient advocacy (4)
Patient recruitment (407)
Patient selection (50)
Peanut (31)
People (34492)
Peptides (30)
Pharmaceutical (30)
Pharmacy benefit managers (22)
Phase 1 (8346)
Phase 2 (12137)
Phase 3 (10404)
Pipeline (7528)
Policy (187)
Postmarket research (1199)
Preclinical (3534)
Press Release (28)
Prostate cancer (237)
Psychedelics (36)
Radioligand (2)
Radiopharmaceuticals (184)
Rare diseases (685)
Real estate (2800)
Recruiting (26)
Regenerative medicine (20)
Regulatory (12078)
Reports (39)
Research institute (2250)
Resumes & cover letters (37)
Rett syndrome (37)
RNA editing (9)
RSV (40)
Saudi Arabia (1)
Schizophrenia (103)
Series A (223)
Series B (168)
Service/supplier (5)
Sickle cell disease (76)
Special edition (16)
Spinal muscular atrophy (76)
Sponsored (18)
Startups (2146)
Stem cells (5)
Stomach cancer (5)
Substance use disorders (12)
Supply chain (76)
Switzerland (13)
Tariffs (40)
Tax incentives (1)
The Weekly (31)
Vaccines (622)
Venture capital (95)
Weight loss (233)
Wet AMD (4)
Women's health (115)
Worklife (6)
Date
Today (70)
Last 7 days (408)
Last 30 days (2044)
Last 365 days (16668)
2026 (15261)
2025 (16013)
2024 (18215)
2023 (20873)
2022 (28889)
2021 (31588)
2020 (30907)
2019 (27195)
2018 (20296)
2017 (15655)
2016 (16347)
2015 (19110)
2014 (14457)
2013 (12093)
2012 (12505)
2011 (12648)
2010 (10693)
Location
Africa (422)
Alabama (95)
Alaska (3)
Arizona (233)
Arkansas (10)
Asia (20320)
Australia (3603)
California (9335)
Canada (2182)
China (767)
Colorado (465)
Connecticut (340)
Delaware (267)
Europe (46641)
Florida (1268)
Georgia (297)
Hawaii (3)
Idaho (32)
Illinois (868)
India (120)
Indiana (416)
Iowa (16)
Japan (461)
Kansas (56)
Kentucky (49)
Louisiana (51)
Maine (35)
Maryland (902)
Massachusetts (5419)
Michigan (241)
Minnesota (448)
Mississippi (4)
Missouri (138)
Montana (11)
Nebraska (19)
Nevada (89)
New Hampshire (48)
New Jersey (2639)
New Mexico (17)
New York (2427)
North Carolina (1136)
North Dakota (6)
Northern California (4756)
Ohio (277)
Oklahoma (18)
Oregon (29)
Pennsylvania (1650)
Puerto Rico (14)
Rhode Island (33)
South America (542)
South Carolina (58)
South Dakota (1)
Southern California (3756)
Tennessee (217)
Texas (1453)
United States (31080)
Utah (305)
Vermont (1)
Virginia (190)
Washington D.C. (58)
Washington State (671)
West Virginia (4)
Wisconsin (94)
Wyoming (2)
371,429 Results for "california healthcare institute chi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KROMATID Selected as Industry Resource Partnership Program Member by the California Institute for Regenerative Medicine (CIRM)
October 27, 2026
·
2 min read
Job Trends
11 companies hiring in California now
Looking for a biopharma job in California? Check out the
BioSpace
list of 11 companies hiring life sciences professionals like you.
September 10, 2026
·
2 min read
·
Angela Gabriel
Job Trends
Employment and funding growth fell in 2025: California Life Sciences report
California life sciences jobs declined 1.8% last year, according to the new California Life Sciences sector report. While National Institutes of Health funding and venture capital investment rose, their growth slowed from the previous year.
May 15, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN
September 25, 2026
·
9 min read
Press Releases
Southern California University of Health Sciences Announces Planned Presidential Transition
November 18, 2026
·
5 min read
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Press Releases
TempraMed Expands Institutional Healthcare Network with Meuhedet Health Services, a Leading HMO in Israel, Covering over 1 Million Lives
Acceptance of TempraMed’s products by Meuhedet Health Services strengthens TempraMed’s B2B institutional commercialization strategy as the Company advances reimbursement initiatives and expands relationships with leading healthcare organizations globally Highlights Meuhedet Health Services, Israel’s third-largest Health Maintenance Organization (HMO), serving more than one million insured members, has accepted TempraMed’s flagship VIVI Cap™ and VIVI Epi™ products. TempraMed products are now accepted by two of Israel’s four national HMOs—Maccabi Healthcare Services and Meuhedet—providing institutional access to approximately four million insured lives. The Company is executing a global B2B institutional strategy focused on healthcare organizations, insurers, distributors and government healthcare systems.
July 9, 2026
·
6 min read
Job Trends
17 companies hiring in California
Looking for a biopharma job in California? Check out the
BioSpace
list of 17 companies hiring life sciences professionals like you.
May 14, 2026
·
3 min read
·
Angela Gabriel
Layoffs
9 biotechs will cut at least half their California workforces
Workforce reductions have hit over 1,000 biopharma employees in The Golden State year to date, with pink slips coming from small biotechs and large pharmas. Biotechs have been hit the hardest, with nine companies saying goodbye to at least half their staffs.
November 19, 2026
·
6 min read
·
Angela Gabriel
Press Releases
Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
March 30, 2026
·
4 min read
1 of 37,143
Next